Healthcare >> CEO Interviews >> April 6, 2009
CHARLES STRUBY, Chief Executive Officer of IVAX Diagnostics, Inc., has over 25
years of senior executive experience in the life sciences industry. Most
recently, Dr. Struby served as Senior Director of Business Development of The
Medicines Company, a NASDAQ-listed acute-care pharmaceutical company, from 2006
through 2008. From 2005 through 2006, Dr. Struby served as General Manager of
Kansas City Operations of Harte-Hanks, Inc., a worldwide direct and targeted
marketing company, and as Vice President of The Mattson Jack Group, Inc., a
consulting firm focused on the pharmaceutical and biotech industries. From 1982
through 2004, Dr. Struby served Sanofi-Aventis Pharmaceuticals, Inc., a leading
global pharmaceutical company, in a variety of senior executive positions,
including various Director and Vice President positions. Prior to that time,
Dr. Struby practiced as a Certified Public Accountant. Dr. Struby earned his BS
in Business from Kansas State University, his MS in Accounting from Louisiana
State University and his PhD in Pharmaceutical Sciences from the University of
Missouri at Kansas City. Profile
TWST: Would you begin with a brief historical sketch of Ivax Diagnostics and a picture of what you are doing at the present time?
Dr. Struby: The company is a combination of three separate